ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ABVC BioPharma's enterprise value was $27.46M on Nov 10, 2026, against $3.41B a year earlier. Over the last 5 years it ranged from $3.52M to $3.41B, with a median of $23.15M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $27.46M | -99.0% |
| 2025 | Dec 31, 2025 | $2.68B | +36896.5% |
| 2024 | Dec 31, 2024 | $7.25M | +38.9% |
| 2023 | Dec 29, 2023 | $5.22M | -73.9% |
| 2022 | Dec 30, 2022 | $19.99M | -77.6% |
| 2021 | Dec 31, 2021 | $89.14M | -15.0% |
| 2020 | Dec 31, 2020 | $104.90M | +22.0% |
| 2019 | Dec 31, 2019 | $86.02M | -79.3% |
| 2018 | Dec 31, 2018 | $415.73M | 0.0% |
| 2017 | Dec 29, 2017 | $415.73M | +1.4% |
| 2016 | Dec 30, 2016 | $410.07M | -89.9% |
| 2015 | Dec 31, 2015 | $4.04B | -96.3% |
| 2014 | Nov 28, 2014 | $110.48B | -20.0% |
| 2013 | Dec 31, 2013 | $138.11B | +671.2% |
| 2012 | Dec 31, 2012 | $17.91B | -94.4% |
| 2011 | Dec 30, 2011 | $322.35B | +705.4% |
| 2010 | Dec 31, 2010 | $40.03B | – |
See a number that looks wrong?